157 related articles for article (PubMed ID: 8095224)
1. Evidence for peroxidase-mediated metabolism of cyclophosphamide.
Kanekal S; Kehrer JP
Drug Metab Dispos; 1993; 21(1):37-42. PubMed ID: 8095224
[TBL] [Abstract][Full Text] [Related]
2. In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.
Kubow S; Wells PG
Mol Pharmacol; 1989 Apr; 35(4):504-11. PubMed ID: 2539558
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
[TBL] [Abstract][Full Text] [Related]
4. Cooxidation of cyclophosphamide as an alternative pathway for its bioactivation and lung toxicity.
Smith RD; Kehrer JP
Cancer Res; 1991 Jan; 51(2):542-8. PubMed ID: 1985772
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin H synthase-catalyzed metabolism and DNA binding of 2-naphthylamine.
Boyd JA; Eling TE
Cancer Res; 1987 Aug; 47(15):4007-14. PubMed ID: 3111680
[TBL] [Abstract][Full Text] [Related]
6. Peroxidase-catalyzed metabolism of etoposide (VP-16-213) and covalent binding of reactive intermediates to cellular macromolecules.
Haim N; Nemec J; Roman J; Sinha BK
Cancer Res; 1987 Nov; 47(22):5835-40. PubMed ID: 3117357
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, metabolic activation, and lung toxicity of cyclophosphamide in C57/B16 and ICR mice.
Kanekal S; Fraiser L; Kehrer JP
Toxicol Appl Pharmacol; 1992 May; 114(1):1-8. PubMed ID: 1585362
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
[TBL] [Abstract][Full Text] [Related]
9. Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes.
Flammang TJ; Yamazoe Y; Benson RW; Roberts DW; Potter DW; Chu DZ; Lang NP; Kadlubar FF
Cancer Res; 1989 Apr; 49(8):1977-82. PubMed ID: 2495173
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of cyclophosphamide by lipoxygenases.
Kanekal S; Kehrer JP
Drug Metab Dispos; 1994; 22(1):74-8. PubMed ID: 8149893
[TBL] [Abstract][Full Text] [Related]
11. Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 mice.
Yu WK; Wells PG
Toxicol Appl Pharmacol; 1995 Mar; 131(1):1-12. PubMed ID: 7878664
[TBL] [Abstract][Full Text] [Related]
12. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant.
Liu L; Wells PG
Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459
[TBL] [Abstract][Full Text] [Related]
13. Evidence for metabolism of 3-methylindole by prostaglandin H synthase and mixed-function oxidases in goat lung and liver microsomes.
Formosa PJ; Bray TM
Biochem Pharmacol; 1988 Nov; 37(22):4359-66. PubMed ID: 3143368
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of phenol and hydroquinone to reactive products by macrophage peroxidase or purified prostaglandin H synthase.
Schlosser MJ; Shurina RD; Kalf GF
Environ Health Perspect; 1989 Jul; 82():229-37. PubMed ID: 2551664
[TBL] [Abstract][Full Text] [Related]
15. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens.
Zenser TV; Palmier MO; Mattammal MB; Bolla RI; Davis BB
J Pharmacol Exp Ther; 1983 Oct; 227(1):139-43. PubMed ID: 6413679
[TBL] [Abstract][Full Text] [Related]
17. Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide.
Gurtoo HL; Hipkens JH; Sharma SD
Cancer Res; 1981 Sep; 41(9 Pt 1):3584-91. PubMed ID: 7260917
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone. Requirement for peroxidative metabolism.
Reed GA; Griffin IO; Eling TE
Mol Pharmacol; 1985 Jan; 27(1):109-14. PubMed ID: 3917545
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury.
Kachel DL; Martin WJ
J Pharmacol Exp Ther; 1994 Jan; 268(1):42-6. PubMed ID: 8301583
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase.
Wise RW; Zenser TV; Kadlubar FF; Davis BB
Cancer Res; 1984 May; 44(5):1893-7. PubMed ID: 6424934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
